Safety and tolerability of iobitridol in general and in patients with risk factors: Results in more than 160 000 patients

Abstract Objective To review the safety, the tolerability and the diagnostic effectiveness of iobitridol under daily practice conditions in the general population and at-risk patients in a post-marketing surveillance study. Materials and methods A total of 160 639 patients (55.1% male, 43.6% female,...

Ausführliche Beschreibung